febuxostat has been researched along with Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inkong, P; Nata, N; Ninwisut, N; Satirapoj, B; Supasyndh, O | 1 |
| Harada, M; Hashimoto, K; Kamijo, Y; Yamada, Y; Yamaguchi, A | 1 |
1 trial(s) available for febuxostat and Vascular Diseases
| Article | Year |
|---|---|
Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease.
Topics: C-Reactive Protein; Febuxostat; Humans; Hyperuricemia; Kidney; Renal Insufficiency, Chronic; Uric Acid; Vascular Diseases | 2023 |
1 other study(ies) available for febuxostat and Vascular Diseases
| Article | Year |
|---|---|
Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Comorbidity; Febuxostat; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperuricemia; Japan; Longitudinal Studies; Male; Middle Aged; Prevalence; Renal Agents; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Sex Distribution; Treatment Outcome; Uric Acid; Vascular Diseases; Young Adult | 2017 |